Image

India Crosses 1 Crore HPV Vaccine Doses in 2026

India Crosses 1 Crore HPV Vaccine Doses in 2026

Overview

India has administered over 1 crore HPV vaccine doses under its national campaign. Check the latest coverage figures, leading states, U-WIN platform and key facts for UPSC and other exams.

HPV Vaccination Campaign

India crossed the milestone of 1 crore HPV vaccine doses on 21 November 2026. The campaign reached nearly 87% of its annual target. It aims to protect 14-year-old girls from HPV infections that can cause cervical cancer.

National HPV Vaccination Campaign 2026

Prime Minister Narendra Modi launched the nationwide campaign on 28 February 2026 in Ajmer, Rajasthan. The Ministry of Health and Family Welfare leads the programme.

Under this campaign, the government provides free and voluntary single-dose HPV vaccination to 14-year-old girls. Parents or guardians must give consent before vaccination. Girls can receive the vaccine at designated government health facilities.

The annual target covers about 1.2 crore girls. This estimate comes from the Registrar General of India's 2021 population data.

Official Sources:

India Crosses 1 Crore Doses

India administered more than 1 crore doses in less than nine months. The campaign reached nearly 87% of its annual target by 21 November 2026.

Six states achieved 100% coverage of their identified target populations. These states are Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar.

Uttar Pradesh recorded the highest number of vaccinations. Bihar and Gujarat followed it.

State Girls vaccinated
Uttar Pradesh Over 29.33 lakh
Bihar 13.70 lakh
Gujarat 7.75 lakh

These figures show the wide reach of the campaign across India.

Official Source: PIB – National HPV Vaccination Progress, 21 November 2026

Role of the U-WIN Platform

U-WIN supports the digital management of the vaccination campaign. It helps health officials track beneficiaries and monitor progress in real time.

Parents can use the platform to book vaccination slots and download digital certificates. Health officials can also identify areas where eligible girls have not yet received the vaccine.

Official Source: PIB – HPV Vaccination Campaign

What Is HPV?

Human Papillomavirus (HPV) refers to a group of viruses. Some types cause genital warts, while high-risk types can cause cancer.

Persistent infection with high-risk HPV can lead to cervical cancer. HPV types 16 and 18 cause about 70% of cervical cancer cases worldwide, according to the World Health Organization (WHO).

Vaccination helps prevent infections from the HPV types covered by the vaccine. It does not treat an existing HPV infection.

Official Source: WHO – Human Papillomavirus and Cancer

How Do HPV Vaccines Work?

HPV vaccines use virus-like particles (VLPs). Think of them as empty shells that look like the outer surface of the virus. They help the immune system recognise HPV and build protection.

These particles use the L1 protein. They do not contain the virus's genetic material and cannot cause HPV infection.

Official Source: WHO – HPV Vaccine Information

CERVAVAC: India's Indigenous HPV Vaccine

CERVAVAC is India's first indigenously developed quadrivalent HPV vaccine. Serum Institute of India developed it with support from the Department of Biotechnology (DBT), BIRAC and other partners.

It targets four HPV types:

  • HPV 6 and 11, which can cause genital warts.

  • HPV 16 and 18, which can cause cervical and other cancers.

The World Health Organization granted CERVAVAC prequalification in October 2026. This allows UN agencies to consider it for procurement.

Official Sources:

Why Is HPV Vaccination Important?

Cervical cancer remains a major health concern for women. HPV vaccination can prevent many infections that lead to this disease.

Vaccination works best as a preventive step before exposure to the virus. However, it does not replace cervical cancer screening. Screening remains necessary because HPV vaccines do not protect against every cancer-causing HPV type.

Official Source: WHO – Cervical Cancer Screening and HPV Vaccination

Exam-Focused Points :

  • India crossed 1 crore HPV vaccine doses on 21 November 2026.

  • Prime Minister Narendra Modi launched the campaign on 28 February 2026.

  • The campaign targets 14-year-old girls.

  • The government provides free, voluntary single-dose vaccination with parental consent.

  • Six states achieved 100% coverage of their identified target populations.

  • HPV types 16 and 18 cause about 70% of cervical cancer cases worldwide.

  • CERVAVAC is India's indigenous quadrivalent HPV vaccine.

FAQs :

Q1. What does HPV stand for?

Ans: Human Papillomavirus.

Q2. When did India launch its National HPV Vaccination Campaign?

Ans: 28 February 2026.

Q3. Who can receive the free vaccine under the national campaign?

Ans: Eligible 14-year-old girls.

Q4. Which HPV types cause about 70% of cervical cancer cases worldwide?

Ans: HPV types 16 and 18.

Q5. What is CERVAVAC?

Ans: It is India's indigenous quadrivalent HPV vaccine.

Month: 

Category: 

1